BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
about
Critical effects of epigenetic regulation in pulmonary arterial hypertension.Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cellsConsequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
P2860
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
@en
type
label
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
@en
prefLabel
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
@en
P2860
P921
P1476
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension
@en
P2093
Mar Orriols
Peter Ten Dijke
P2860
P2888
P304
P356
10.1007/S00018-017-2510-4
P5008
P577
2017-04-26T00:00:00Z